Skip to main content
DMPTool logo

Plans (67)

NIH-Default DMSP

Regulation of Zn2+ translocation through the mitochondrial Ca2+ uniporter (MCU) and ischemic brain injury

John Weiss, University of California, Irvine
NIH-Default DMSP

cAMP and biofilm formation

George O'toole, Dartmouth College (dartmouth.edu)
NIH-Default DMSP

Disparities in Substance Use and Mental Health for Women by Sexual Orientation: Identifying Modifiable Risk and Protective Factors during the COVID-19 Pandemic Using Multiple Sources of Health Data

Kristie Seelman, Georgia State University (gsu.edu)
NIH-Default DMSP

The study and improvement of data collection and management for infectious diseases and immunodeficiencies

Emily Ricotta, National Institutes of Health (nih.gov)
NIH-Default DMSP

IRF3 and macrophage polarization during experimental periodontitis

Tom Petro, University of Nebraska Medical Center (unmc.edu)
NIH-Default DMSP

Transcriptional Dysregulation in the Pathogenesis of NAFLD

Baran Ersoy, Weill Cornell Medicine
NIH-Default DMSP

Racial Equity Tools to Prevent Youth Violence and to Reduce Racially Inequitable Youth Outcomes (Racial Equity Project, REP) in Worcester, MA.

Laurie Ross, Clark University (clarku.edu)
NIH-Default DMSP

Signature for Pain Recovery IN Teens (SPRINT)

Emma Biggs, Stanford University (stanford.edu)
NIH-GEN: Generic (Current until 2023)

Blocking the long noncoding RNA, INCR1, with an antisense oligonucleotide (ASO) to reverse GBM immuno-evasion”

E.antonio Chiocca, PSC Partners Seeking a Cure (pscpartners.org)